Alnylam Pharmaceuticals shares owned by Antipodes Partners
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Antipodes Partners
from 13F filings
Historical chart of Antipodes Partners investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Antipodes Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Antipodes Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 32k | 456.03 |
| 2025-06-30 | $40M | 123k | 326.11 |
| 2025-03-31 | $43M | 160k | 270.04 |
| 2024-12-31 | $32M | 134k | 235.33 |
| 2024-09-30 | $38M | 139k | 275.05 |
| 2024-06-30 | $1.6B | 239k | 6612.00 |
| 2024-03-31 | $31M | 206k | 149.45 |
| 2023-12-31 | $36M | 189k | 191.41 |
| 2023-09-30 | $20M | 112k | 174.03 |
| 2023-06-30 | $10k | 56 | 178.57 |
| 2023-03-31 | $28k | 140 | 200.00 |
| 2022-12-31 | $28k | 118 | 237.29 |